Brigatinib, a new treatment option in ALK-rearranged advanced non-small cell lung carcinoma

被引：0
作者：
Leprieur, Etienne Giroux [1 ,2 ]
Wislez, Marie [3 ,4 ]
机构：
[1] Hop Ambroise Parc, AP HP, Serv Pneumol & Oncol Thorac, Boulogne, France
[2] Univ Paris Saclay, UVSQ, EA4340, Paris, France
[3] Hop Tenon, AP HP, Serv Pneumol, 4 Rue Chine, F-75970 Paris, France
[4] Univ Paris 06, UPMC, Sorbonne Univ, GRC 04, Paris, France
来源：
TRANSLATIONAL CANCER RESEARCH | 2017年 / 6卷
关键词：
OPEN-LABEL; CANCER; CRIZOTINIB; CHEMOTHERAPY; INHIBITORS; CERITINIB; SAFETY;
D O I：
10.21037/tcr.2017.09.02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S173 / S176
页数：4
相关论文
共 15 条
[1]   Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT) [J].
Barlesi, Fabrice ;
Mazieres, Julien ;
Merlio, Jean-Philippe ;
Debieuvre, Didier ;
Mosser, Jean ;
Lena, Herve ;
Ouafik, L'Houcine ;
Besse, Benjamin ;
Rouquette, Isabelle ;
Westeel, Virginie ;
Escande, Fabienne ;
Monnet, Isabelle ;
Lemoine, Antoinette ;
Veillon, Remi ;
Blons, Helene ;
Audigier-Valette, Clarisse ;
Bringuier, Pierre-Paul ;
Lamy, Regine ;
Beau-Faller, Michele ;
Pujol, Jean-Louis ;
Sabourin, Jean-Christophe ;
Penault-Llorca, Frederique ;
Denis, Marc G. ;
Lantuejoul, Sylvie ;
Morin, Franck ;
Quan Tran ;
Missy, Pascale ;
Langlais, Alexandra ;
Milleron, Bernard ;
Cadranel, Jacques ;
Soria, Jean-Charles ;
Zalcman, Gerard .
LANCET, 2016, 387 (10026) :1415-1426
[2]   Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2 [J].
Crino, Lucio ;
Ahn, Myung-Ju ;
De Marinis, Filippo ;
Groen, Harry J. M. ;
Wakelee, Heather ;
Hida, Toyoaki ;
Mok, Tony ;
Spigel, David ;
Felip, Enriqueta ;
Nishio, Makoto ;
Scagliotti, Giorgio ;
Branle, Fabrice ;
Emeremni, Chetachi ;
Quadrigli, Massimiliano ;
Zhang, Jie ;
Shaw, Alice T. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (24) :2866-+
[3]   Expanding the Roster of ROS1 Inhibitors [J].
Dagogo-Jack, Ibiayi ;
Shaw, Alice T. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (23) :2595-+
[4]   Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1) [J].
Drilon, Alexander ;
Siena, Salvatore ;
Ou, Sai-Hong Ignatius ;
Patel, Manish ;
Ahn, Myung Ju ;
Lee, Jeeyun ;
Bauer, Todd M. ;
Farago, Anna F. ;
Wheler, Jennifer J. ;
Liu, Stephen V. ;
Doebele, Robert ;
Giannetta, Laura ;
Cerea, Giulio ;
Marrapese, Giovanna ;
Schirru, Michele ;
Amatu, Alessio ;
Bencardino, Katia ;
Palmeri, Laura ;
Sartore-Bianchi, Andrea ;
Vanzulli, Angelo ;
Cresta, Sara ;
Damian, Silvia ;
Duca, Matteo ;
Ardini, Elena ;
Li, Gang ;
Christiansen, Jason ;
Kowalski, Karey ;
Johnson, Ann D. ;
Patel, Rupal ;
Luo, David ;
Chow-Maneval, Edna ;
Hornby, Zachary ;
Multani, Pratik S. ;
Shaw, Alice T. ;
De Braud, Filippo G. .
CANCER DISCOVERY, 2017, 7 (04) :400-409
[5]   Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study [J].
Duruisseaux, Michael ;
Besse, Benjamin ;
Cadranel, Jacques ;
Perol, Maurice ;
Mennecier, Bertrand ;
Bigay-Game, Laurence ;
Descourt, Renaud ;
Dansin, Eric ;
Audigier-Valette, Clarisse ;
Moreau, Lionel ;
Hureaux, Jose ;
Veillon, Remi ;
Otto, Josiane ;
Madroszyk-Flandin, Anne ;
Cortot, Alexis ;
Guichard, Francois ;
Boudou-Rouquette, Pascaline ;
Langlais, Alexandra ;
Missy, Pascale ;
Morin, Franck ;
Moro-Sibilot, Denis .
ONCOTARGET, 2017, 8 (13) :21903-21917
[6]   Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer [J].
Gainor, Justin F. ;
Dardaei, Leila ;
Yoda, Satoshi ;
Friboulet, Luc ;
Leshchiner, Ignaty ;
Katayama, Ryohei ;
Dagogo-Jack, Ibiayi ;
Gadgeel, Shirish ;
Schultz, Katherine ;
Singh, Manrose ;
Chin, Emily ;
Parks, Melissa ;
Lee, Dana ;
DiCecca, Richard H. ;
Lockerman, Elizabeth ;
Huynh, Tiffany ;
Logan, Jennifer ;
Ritterhouse, Lauren L. ;
Le, Long P. ;
Muniappan, Ashok ;
Digumarthy, Subba ;
Channick, Colleen ;
Keyes, Colleen ;
Getz, Gad ;
Dias-Santagata, Dora ;
Heist, Rebecca S. ;
Lennerz, Jochen ;
Sequist, Lecia V. ;
Benes, Cyril H. ;
Iafrate, A. John ;
Mino-Kenudson, Mari ;
Engelman, Jeffrey A. ;
Shaw, Alice T. .
CANCER DISCOVERY, 2016, 6 (10) :1118-1133
[7]   Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial [J].
Gettinger, Scott N. ;
Bazhenova, Lyudmila A. ;
Langer, Corey J. ;
Salgia, Ravi ;
Gold, Kathryn A. ;
Rosell, Rafael ;
Shaw, Alice T. ;
Weiss, Glen J. ;
Tugnait, Meera ;
Narasimhan, Narayana I. ;
Dorer, David J. ;
Kerstein, David ;
Rivera, Victor M. ;
Clackson, Timothy ;
Haluska, Frank G. ;
Camidge, David Ross .
LANCET ONCOLOGY, 2016, 17 (12) :1683-1696
[8]   Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial [J].
Kim, Dong-Wan ;
Tiseo, Marcello ;
Ahn, Myung-Ju ;
Reckamp, Karen L. ;
Hansen, Karin Holmskov ;
Kim, Sang-We ;
Huber, Rudolf M. ;
West, Howard L. ;
Groen, Harry J. M. ;
Hochmair, Maximilian J. ;
Leighl, Natasha B. ;
Gettinger, Scott N. ;
Langer, Corey J. ;
Rodriguez, Luis G. Paz-Ares ;
Smit, Egbert F. ;
Kim, Edward S. ;
Reichmann, William ;
Haluska, Frank G. ;
Kerstein, David ;
Camidge, D. Ross .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (22) :2490-+
[9]   Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer [J].
Peters, Solange ;
Camidge, D. Ross ;
Shaw, Alice T. ;
Gadgeel, Shirish ;
Ahn, Jin S. ;
Kim, Dong-Wan ;
Ou, Sai-Hong I. ;
Perol, Maurice ;
Dziadziuszko, Rafal ;
Rosell, Rafael ;
Zeaiter, Ali ;
Mitry, Emmanuel ;
Golding, Sophie ;
Balas, Bogdana ;
Noe, Johannes ;
Morcos, Peter N. ;
Mok, Tony .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09) :829-838
[10]   Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial [J].
Shaw, Alice T. ;
Gandhi, Leena ;
Gadgeel, Shirish ;
Riely, Gregory J. ;
Cetnar, Jeremy ;
West, Howard ;
Camidge, D. Ross ;
Socinski, Mark A. ;
Chiappori, Alberto ;
Mekhail, Tarek ;
Chao, Bo H. ;
Borghaei, Hossein ;
Gold, Kathryn A. ;
Zeaiter, Ali ;
Bordogna, Walter ;
Balas, Bogdana ;
Puig, Oscar ;
Henschel, Volkmar ;
Ou, Sai-Hong Ignatius .
LANCET ONCOLOGY, 2016, 17 (02) :234-242
12